Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma: Original article: Clinical investigations

International Journal of Urology

Volumn 16, Issue 7, 2009, Pages 616-621

  May, Matthias ^a   Brookman Amissah, Sabine ^a   Kendel, Friederike ^b   Knoll, Nina ^b   Roigas, Jan ^b   Hoschke, Bernd ^c   Miller, Kurt ^d   Gilfrich, Christian ^a   Pflanz, Sandra ^c   Gralla, Oliver ^d  

^a Urologische Klinik   (Germany)

^b Biometric Working Group   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d CARL THIEM KLINIKUM   (Germany)

Author keywords

Nephrectomy; Prognostic parameter; Renal cell carcinoma; Sao Paulo score; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; NEPHRECTOMY; PARTIAL NEPHRECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEPHRECTOMY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 68149142314     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02319.x     Document Type: Article

References (14)

1. Wallen EM, Pruthi RS, Joyce GF, Wise M. Urologic Diseases in America Project. Kidney cancer. J. Urol. 2007 177 : 2006 18 discussion 2018 19.
2. Méjean A, Oudard S, Thiounn N. Prognostic factors of renal cell carcinoma. J. Urol. 2003 169 : 821 7. Review.
3. Ficarra V, Martignoni G, Maffei N et al. Original and reviewed nuclear grading according to the Fuhrman system: A multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 2005 103 : 68 75.
4. Dall'Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. J. Urol. 2007 177 : 1687 91.
5. Thompson RH, Leibovich BC, Lohse CM et al. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: The D-SSIGN score. J. Urol. 2007 177 : 477 80.
6. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumour stage, size, grade and necrosis: The SSIGN score. J. Urol. 2002 168 : 2395 400.
7. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J. Urol. 2001 166 : 63 7.
8. Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA et al. Microvascular tumour invasion, tumour size and Fuhrman grade: A pathological triad for prognostic evaluation of renal cell carcinoma. J. Urol. 2007 178 : 425 8 discussion 428. Epub 2007 Jun 11.
9. Madbouly K, Al-Qahtani SM, Ghazwani Y, Al-Shaibani S, Mansi MK. Microvascular tumour invasion: Prognostic significance in low-stage renal cell carcinoma. Urology 2007 69 : 670 4.
10. Leibovich BC, Blute ML, Cheville JC et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: A stratification tool for prospective clinical trials. Cancer 2003 97 : 1663 71.
11. Salama ME, Guru K, Stricker H et al. pT1 substaging in renal cell carcinoma: Validation of the 2002 TNM staging modification of malignant renal epithelial tumours. J. Urol. 2005 173 : 1492 5.
12. Klatte T, Patard JJ, Goel RH et al. Prognostic impact of tumour size on pT2 renal cell carcinoma: An international multicenter experience. J. Urol. 2007 178 : 35 40 discussion 40. Epub 2007 May 22. (Pubitemid 46898490)
13. Kuczyk M, Wegener G, Merseburger AS et al. Impact of tumour size on the long-term survival of patients with early stage renal cell cancer. World J. Urol. 2005 23 : 50 4. Epub 2005 Feb 24.
14. Banks RE, Craven RA, Harnden P, Madaan S, Joyce A, Selby PJ. Key clinical issues in renal cancer: A challenge for proteomics. World J. Urol. 2007 25 : 537 56. Epub 2007 Aug 25. Review.